- Home
- ALEX vs ARDX Comparison
ALEX vs ARDX Comparison
Compare ALEX & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEX
- ARDX
- Stock Information
- Founded
- ALEX 1870
- ARDX 2007
- Country
- ALEX United States
- ARDX United States
- Employees
- ALEX N/A
- ARDX N/A
- Industry
- ALEX Real Estate Investment Trusts
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- ALEX Real Estate
- ARDX Health Care
- Exchange
- ALEX Nasdaq
- ARDX Nasdaq
- Market Cap
- ALEX 1.4B
- ARDX 1.4B
- IPO Year
- ALEX N/A
- ARDX 2014
- Fundamental
- Price
- ALEX $19.30
- ARDX $4.97
- Analyst Decision
- ALEX Strong Buy
- ARDX Buy
- Analyst Count
- ALEX 4
- ARDX 7
- Target Price
- ALEX $21.67
- ARDX $11.75
- AVG Volume (30 Days)
- ALEX 276.2K
- ARDX 5.5M
- Earning Date
- ALEX 10-24-2024
- ARDX 10-31-2024
- Dividend Yield
- ALEX 4.62%
- ARDX N/A
- EPS Growth
- ALEX N/A
- ARDX N/A
- EPS
- ALEX 0.61
- ARDX N/A
- Revenue
- ALEX $230,949,000.00
- ARDX $251,849,000.00
- Revenue This Year
- ALEX N/A
- ARDX $167.24
- Revenue Next Year
- ALEX $2.08
- ARDX $18.93
- P/E Ratio
- ALEX $23.54
- ARDX N/A
- Revenue Growth
- ALEX 1.30
- ARDX 87.57
- 52 Week Low
- ALEX $15.53
- ARDX $4.01
- 52 Week High
- ALEX $20.30
- ARDX $10.13
- Technical
- Relative Strength Index (RSI)
- ALEX 53.63
- ARDX 40.39
- Support Level
- ALEX $19.01
- ARDX $4.43
- Resistance Level
- ALEX $19.97
- ARDX $6.53
- Average True Range (ATR)
- ALEX 0.33
- ARDX 0.42
- MACD
- ALEX 0.03
- ARDX -0.12
- Stochastic Oscillator
- ALEX 53.47
- ARDX 28.73
About ALEX Alexander & Baldwin Inc. REIT Holding Company
Alexander & Baldwin Inc operates in the real estate sector. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces and also urban ground leases in Hawaii, thereby accounting for majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.